These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 29895052)

  • 1. Tdap vaccination during pregnancy to protect newborns from pertussis infection.
    Mazzilli S; Tavoschi L; Lopalco PL
    Ann Ig; 2018; 30(4):346-363. PubMed ID: 29895052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
    Munoz FM; Bond NH; Maccato M; Pinell P; Hammill HA; Swamy GK; Walter EB; Jackson LA; Englund JA; Edwards MS; Healy CM; Petrie CR; Ferreira J; Goll JB; Baker CJ
    JAMA; 2014 May; 311(17):1760-9. PubMed ID: 24794369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Halperin SA; Langley JM; Ye L; MacKinnon-Cameron D; Elsherif M; Allen VM; Smith B; Halperin BA; McNeil SA; Vanderkooi OG; Dwinnell S; Wilson RD; Tapiero B; Boucher M; Le Saux N; Gruslin A; Vaudry W; Chandra S; Dobson S; Money D
    Clin Infect Dis; 2018 Sep; 67(7):1063-1071. PubMed ID: 30010773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
    Kandeil W; van den Ende C; Bunge EM; Jenkins VA; Ceregido MA; Guignard A
    Expert Rev Vaccines; 2020 Jul; 19(7):621-638. PubMed ID: 32772755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
    Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
    Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
    Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Skoff TH; Blain AE; Watt J; Scherzinger K; McMahon M; Zansky SM; Kudish K; Cieslak PR; Lewis M; Shang N; Martin SW
    Clin Infect Dis; 2017 Nov; 65(12):1977-1983. PubMed ID: 29028938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.
    Winter K; Nickell S; Powell M; Harriman K
    Clin Infect Dis; 2017 Jan; 64(1):3-8. PubMed ID: 27624955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
    Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
    Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
    MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.
    Maertens K; Caboré RN; Huygen K; Hens N; Van Damme P; Leuridan E
    Vaccine; 2016 Jan; 34(1):142-50. PubMed ID: 26592142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(7):131-5. PubMed ID: 23425962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
    Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
    Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.